Engineering IL-2 to steer immune responses

被引：0
|
作者：
Li, Xian C. [1 ,2 ]
机构：
[1] Houston Methodist Hosp Texas, Immunobiol & Transplant Sci Ctr, Houston, TX 77030 USA
[2] Houston Methodist Hosp Texas, Dept Surg, Houston, TX 77030 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷 / 01期
关键词：
D O I：
10.1111/ajt.16640
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [41] Loss of immune tolerance to IL-2 in type 1 diabetes
    Louis Pérol
    John M. Lindner
    Pamela Caudana
    Nicolas Gonzalo Nunez
    Audrey Baeyens
    Andrea Valle
    Christine Sedlik
    Delphine Loirat
    Olivier Boyer
    Alain Créange
    José Laurent Cohen
    Ute Christine Rogner
    Jun Yamanouchi
    Martine Marchant
    Xavier Charles Leber
    Meike Scharenberg
    Marie-Claude Gagnerault
    Roberto Mallone
    Manuela Battaglia
    Pere Santamaria
    Agnès Hartemann
    Elisabetta Traggiai
    Eliane Piaggio
    Nature Communications, 7
  • [42] MANAGEMENT OF A NOVEL IMMUNE-DEFICIENCY WITH IL-2 THERAPY
    PAHWA, R
    PARADISE, C
    GOOD, RA
    CANCER TREATMENT REVIEWS, 1989, 16 : 143 - 149
  • [43] Loss of immune tolerance to IL-2 in type 1 diabetes
    Perol, Louis
    Lindner, John M.
    Caudana, Pamela
    Nunez, Nicolas Gonzalo
    Baeyens, Audrey
    Valle, Andrea
    Sedlik, Christine
    Loirat, Delphine
    Boyer, Olivier
    Creange, Alain
    Cohen, Jose Laurent
    Rogner, Ute Christine
    Yamanouchi, Jun
    Marchant, Martine
    Leber, Xavier Charles
    Scharenberg, Meike
    Gagnerault, Marie-Claude
    Mallone, Roberto
    Battaglia, Manuela
    Santamaria, Pere
    Hartemann, Agnes
    Traggiai, Elisabetta
    Piaggio, Eliane
    NATURE COMMUNICATIONS, 2016, 7
  • [44] RECEPTORS FOR IL-2 IN TISSUES ALIEN TO THE IMMUNE-SYSTEM
    FINK, S
    ALONSO, GF
    MOLINOLO, A
    DEBRACCO, MME
    MEDICINA-BUENOS AIRES, 1987, 47 (06) : 629 - 630
  • [45] INTERLEUKIN-2 (IL-2) UPREGULATES IL-2 RECEPTOR EXPRESSION - EVIDENCE THAT IL-2 AUGMENTS IL-2 RECEPTOR MESSENGER-RNA
    DEPPER, J
    LEONARD, W
    DROGULA, C
    KRONKE, M
    WALDMANN, T
    GREENE, W
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 786 - 786
  • [46] CLINICAL AND IMMUNE-RESPONSES OF TUBERCULOSIS PATIENTS TREATED WITH LOW-DOSE IL-2 AND MULTIDRUG THERAPY
    JOHNSON, BJ
    RESS, SR
    WILLCOX, P
    PATI, BP
    LORGAT, F
    STEAD, P
    SAHA, R
    LUKEY, P
    LAOCHUMROONVORAPONG, P
    CORRAL, L
    KAPLAN, G
    CYTOKINES AND MOLECULAR THERAPY, 1995, 1 (03): : 185 - 196
  • [47] Oncolytic Adenoviruses Armed with TNFa and IL-2 Induce Antitumor Immune Responses and Protection from Tumor Rechallenge
    Havunen, Riikka
    Siurala, Mikko
    Parviainen, Suvi
    Behr, Michael
    Nettelbeck, Dirk
    Ehrhardt, Anja
    Hemminki, Akseli
    MOLECULAR THERAPY, 2016, 24 : S162 - S162
  • [48] Immunotherapy: Robust responses to intraperitoneal IL-2 in ovarian cancer
    Hutchinson L.
    Nature Reviews Clinical Oncology, 2010, 7 (3) : 122 - 122
  • [49] IL-25 promotes TH2 responses through the induction of IL-2
    Zaph, Colby
    Artis, David
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [50] IL-2 adenovector-transduced autologous tumor cells reduce antitumor immune responses in patients with neuroblastoma
    Bowman, L
    Grossmann, M
    Rill, D
    Brown, M
    Zhong, WY
    Alexander, B
    Leimig, T
    Coustan-Smith, E
    Campana, D
    Jenkins, J
    Woods, D
    Kitchingman, G
    Vanin, E
    Brenner, M
    BLOOD, 1998, 92 (06) : 1941 - 1949
12345